The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Title |
The effect of adding inhaled corticosteroids to tiotropium and long‐acting beta<sub>2</sub>‐agonists for chronic obstructive pulmonary disease
|
---|---|
Published in |
Cochrane database of systematic reviews, September 2011
|
DOI | 10.1002/14651858.cd009039.pub2 |
Pubmed ID | |
Authors |
Charlotta Karner, Christopher J Cates |
Abstract |
Long-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropium are commonly used, either on their own or in combination, for managing persistent symptoms of chronic obstructive pulmonary disease. Patients with severe chronic obstructive pulmonary disease who are symptomatic and who suffer repeated exacerbations are recommended to add inhaled corticosteroids to their bronchodilator treatment. However, the benefits and risks of adding inhaled corticosteroid to tiotropium and long-acting beta(2)-agonists for the treatment of chronic obstructive pulmonary disease are unclear. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 2% |
United States | 1 | <1% |
Tunisia | 1 | <1% |
Unknown | 127 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 20 | 15% |
Student > Master | 14 | 11% |
Other | 11 | 8% |
Student > Bachelor | 10 | 8% |
Student > Postgraduate | 10 | 8% |
Other | 30 | 23% |
Unknown | 36 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 56 | 43% |
Nursing and Health Professions | 11 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 5% |
Social Sciences | 5 | 4% |
Biochemistry, Genetics and Molecular Biology | 3 | 2% |
Other | 12 | 9% |
Unknown | 38 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2013.
All research outputs
#20,723,696
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#10,914
of 11,499 outputs
Outputs of similar age
#113,661
of 136,570 outputs
Outputs of similar age from Cochrane database of systematic reviews
#102
of 108 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 136,570 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.